z-logo
open-access-imgOpen Access
Single fraction of HDR brachytherapy for prostate cancer: Results of the SiFEPI phase II prospective trial
Author(s) -
JeanMichel HannounLévi,
Marie-Eve Chand-Fouché,
Tanguy PaceLoscos,
Mathieu Gautier,
Jocelyn Gal,
Renaud Schiappa,
Nina Pujol
Publication year - 2022
Publication title -
clinical and translational radiation oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.336
H-Index - 15
ISSN - 2405-6308
DOI - 10.1016/j.ctro.2022.08.007
Subject(s) - medicine , prostate cancer , prostate , urology , brachytherapy , prospective cohort study , radiation therapy , nuclear medicine , gastroenterology , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom